Literature DB >> 14990594

Tumour angiogenic activity and vascular survival ability in bladder carcinoma.

I Papadopoulos1, A Giatromanolaki, M I Koukourakis, E Sivridis.   

Abstract

BACKGROUND: Tumour angiogenic activity (TAA) is an important prognostic factor in many human tumours, including transitional cell carcinomas of the urinary bladder. The new tumour vessels are formed in the invading tumour front. This peripheral tumour area is internalised as soon as the growing tumour forms a new front. AIMS: To investigate and compare TAA with the ability of the tumour vasculature to survive (VSA) in inner tumour areas.
METHODS: Fifty one cystectomy specimens with transitional cell carcinoma of the urinary bladder were studied. Sections were stained immunohistochemically for endothelial cells and proliferation activity, using the monoclonal antibodies CD31 and MIB-1, respectively. TAA was studied at the invading tumour edge-designated as the mean number of blood vessels in three "hot spots" at this site. VSA was assessed by comparing the vascular density in peripheral and inner tumour areas.
RESULTS: High TAA at the invading tumour edge significantly correlated with lymph node involvement, but not with patient survival. Extensive lymphocytic infiltration was more frequent in tumours with high TAA. VSA was significantly higher in tumours of high proliferation index, high histological grade, advanced T stage, and poor prognosis. However, there was no association with metastasis to regional lymph nodes.
CONCLUSION: VSA and TAA provide a more complete profile of the tumour vasculature and are associated with aggressive tumour behaviour in transitional cell carcinomas of the urinary bladder. The qualitative information provided by VSA may be important for the identification of angiogenic tumours with differential responses to various antiangiogenic treatments.

Entities:  

Mesh:

Year:  2004        PMID: 14990594      PMCID: PMC1770238          DOI: 10.1136/jcp.2003.012005

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.

Authors:  K Inoue; J W Slaton; T Karashima; C Yoshikawa; T Shuin; P Sweeney; R Millikan; C P Dinney
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

Review 2.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 3.  Angiogenesis, angiogenic factor expression and prognosis of bladder cancer.

Authors:  E H Streeter; J P Crew
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

Review 4.  Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs.

Authors:  S B Fox; G Gasparini; A L Harris
Journal:  Lancet Oncol       Date:  2001-05       Impact factor: 41.316

5.  Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer.

Authors:  P Korkolopoulou; A E Konstantinidou; N Kavantzas; E Patsouris; P M Pavlopoulos; P Christodoulou; E Thomas-Tsagli; P Davaris
Journal:  Virchows Arch       Date:  2001-06       Impact factor: 4.064

6.  Cancer vascularization: implications in radiotherapy?

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; I Fezoulidis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-09-01       Impact factor: 7.038

7.  Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.

Authors:  A Giatromanolaki; G P Stathopoulos; E Tsiompanou; E Tsiobanou; C Papadimitriou; V Georgoulias; K C Gatter; A L Harris; M I Koukourakis
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

8.  'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; K O'Byrne; K C Gatter; A L Harris
Journal:  J Pathol       Date:  2000-10       Impact factor: 7.996

9.  Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?

Authors:  O Sağol; K Yörükoğlu; B Sis; B Tuna; E Ozer; M Güray; U Mungan; Z Kirkali
Journal:  Urology       Date:  2001-05       Impact factor: 2.649

10.  Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.

Authors:  A Giatromanolaki; M I Koukourakis; D Theodossiou; K Barbatis; K O'Byrne; A L Harris; K C Gatter
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

View more
  4 in total

1.  Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors.

Authors:  Luciana Regina Moreira; André Almeida Schenka; Paulo Latuf-Filho; André Lisboa Penná; Carmen S P Lima; Fernando Augusto Soares; Miriam Aparecida Silva Trevisan; José Vassallo
Journal:  Tumour Biol       Date:  2011-01-08

2.  A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG.

Authors:  Kimberly R Kanigel Winner; James C Costello
Journal:  Pac Symp Biocomput       Date:  2017

3.  Angiogenesis and vascular survival ability in ovarian adenocarcinomas.

Authors:  A Giatromanolaki; E Sivridis; P Tsikouras; I Manavis; G Maroulis; M I Koukourakis
Journal:  Virchows Arch       Date:  2004-09-09       Impact factor: 4.064

4.  Study of Proliferating cell nuclear antigen expression and Angiogenesis in Urothelial neoplasms: Correlation with tumor grade and stage.

Authors:  Poojan Agarwal; Achin Kumar Sen; Minakshi Bhardwaj; Veronique Dinand; Arvind Ahuja; Rajeev Sood
Journal:  Urol Ann       Date:  2018 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.